Delivery Order 75F40121D00007-75F40123F19005
Award Date 8/29/23
Potential Completion Date 3/30/24
Potential Value $33K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $61,236 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, barcoded overhang adapter kits, Sequel binding and internal control kit, Sequel pipet tips V2, Sequel sequencing kit, Sequel SMRT cell oil, SMRT Cell 1M V3 tray, and SMRTbell Express template prep. Performance will take place in Silver Spring, Maryland through...
- The Department of Health and Human Services Food and Drug Administration awarded a $43,337.06 firm fixed price delivery order to Pacific Biosciences of California, Inc. under the agency's indefinite-delivery/indefinite-quantity contract 75F40121D00007. The delivery order is for the purchase of specific supplies and reagents for use with Pacific Biosciences' PacBio Sequel IIE long-read DNA/RNA sequencer to support the FDA's regulatory science programs. Performance will occur in Laurel, Maryland...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- This contract award is for the purchase of reagents and supplies from Pacific Biosciences of California, Inc. by the U.S. Department of Health and Human Services' Food and Drug Administration. The items include PacBio's proprietary single molecule real-time (SMRT) sequencing consumables such as template prep kits, binding kits, and SMRT cells to support the agency's genomic research initiatives. The $46,548 firm-fixed price delivery order does not utilize a set-aside program. Pacific Biosciences...
- This is a delivery order awarded to Pacific Biosciences of California, Inc., a manufacturer of DNA/RNA sequencing systems and associated consumables, by the Department of Health and Human Services' Food and Drug Administration. The $69,567.00 firm-fixed-price order is for the provision of sequencing reagents, kits, and consumables to support the agency's genomic research initiatives. Pacific Biosciences has extensive experience providing specialized sequencing equipment and supplies to various...
- The Department of Health and Human Services Food and Drug Administration awarded a $406,184 firm fixed price purchase order contract to Pacific Biosciences of California, Inc. for the provision of DNA sequencer and cluster generator hardware and software, as well as four annual preventative maintenance agreements to be exercised annually. The place of performance will be Laurel, Maryland and the period of performance is from September 26, 2023 through October 26, 2028. The contract was set aside...
- Pacific Biosciences of California, Inc. was awarded a $330,220.00 firm-fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to provide a SEQUEL System with accessories, including shipping, training, and a 12-month manufacturer's warranty. The contract is set aside for small businesses. Pacific Biosciences is a manufacturer of scientific equipment, reagents, and services related to DNA/RNA sequencing systems, and has fulfilled over $10 million...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company...
- 75F40121D00007Indefinite Delivery Contract
- 75F40121D00007-75F40123F19005Delivery Order
The Department of Health and Human Services Food and Drug Administration awarded a $33,175 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, HiFi Express Template Prep Kit 2.0, Sequel Binding Kit 3.0, Sequel Sequencing Kit 3.0, and SMRT Cell 1M v3 LR Tray. The place of performance is Silver Spring, Maryland. The contract period runs from August 29, 2023 through March 30, 2024. As the prime contractor, Pacific Biosciences of California, Inc. will provide the requested products to support the FDA's laboratory testing and analysis operations.
Generated 12/19/23, 8:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 8/29/23 |